Tenet Healthcare Corporation (THC) P/E Ratio History
Historical price-to-earnings valuation from 1990 to 2025
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of February 28, 2026, Tenet Healthcare Corporation (THC) trades at a price-to-earnings ratio of 15.5x, with a stock price of $239.39 and trailing twelve-month earnings per share of $16.00.
The current P/E is 44% above its 5-year average of 10.7x. Over the past five years, THC's P/E has ranged from a low of 3.9x to a high of 17.9x, placing the current valuation at the 85th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, THC trades at a 35% discount to its sector peers. The sector includes 224 companies with P/E ratios ranging from 0.0x to 184.4x.
The PEG ratio of 0.47 (P/E divided by -53% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, THC trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our THC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Hospitals and inpatient facilities peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
HCAHCA Healthcare, Inc. | $118B | 18.7 | 0.89 | +29% |
THCTenet Healthcare Corporation | $21B | 15.5 | 0.47 | -53% |
ARDTArdent Health Partners, LLC | $1B | 5.9 | 0.08Best | +351%Best |
UHTUniversal Health Realty Income Trust | $605M | 34.3 | - | -9% |
CYHCommunity Health Systems, Inc. | $485M | 0.9Lowest | - | +197% |
AUNAAuna S.A. | $161M | 11.0 | - | +128% |
UHSUniversal Health Services, Inc. | $3M | 8.9 | 0.56 | +37% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $198.72 | $15.49 | 12.8x | -67% |
| FY2025 Q3 | $203.04 | $14.59 | 13.9x | -64% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $176.00 | $15.62 | 11.3x | -71% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $134.50 | $15.12 | 8.9x | -77% |
| FY2024 Q4 | $126.23 | $32.23 | 3.9x | -90% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $166.20 | $31.21 | 5.3x | -86% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $133.03 | $27.26 | 4.9x | -88% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $105.11 | $25.77 | 4.1x | -90% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $75.57 | $5.71 | 13.2x | -66% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $65.89 | $4.33 | 15.2x | -61% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $81.38 | $4.55 | 17.9x | -54% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $59.42 | $3.75 | 15.8x | -60% |
Average P/E for displayed period: 39.2x
See THC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs THC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare THC vs AGIO
See how THC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is THC stock overvalued or undervalued?
THC trades at 15.5x P/E, above its 5-year average of 10.7x. The 85th percentile ranking indicates a premium to historical valuation.
How does THC's valuation compare to peers?
Tenet Healthcare Corporation P/E of 15.5x compares to sector median of 23.7x. The discount suggests lower growth expectations or higher risk.
What is THC's PEG ratio?
THC PEG ratio is 0.47. Below 1.0 indicates valuation is supported by earnings growth rate. Historical P/E data spans 1990-2025.